相关实验视频
Updated: Jul 25, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
胆酸和非酒精性脂肪肝炎:分子洞察力和治疗点
Zilu Cheng1, Yixiong Chen1, Bernd Schnabl2
1Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei Province 430022, China.
胆汁酸是调节脂质和葡萄糖代谢的关键信号分子. 胆酸平衡中断与非酒精性脂肪肝炎 (NASH) 有关,这表明有治疗潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 胃肠病学 胃肠病学
背景情况:
- 非酒精性脂肪肝炎 (NASH) 是肝移植的主要原因.
- 纳什病原发生是多因素的,涉及代谢功能障碍和遗传因素.
- 目前的NASH治疗方法仍然有限.
研究的目的:
- 阐明胆汁酸在肝脂和葡萄糖代谢中的作用.
- 检查胆汁酸对肝炎和纤维化的影响.
- 讨论针对NASH治疗胆酸通路的药理学药剂.
主要方法:
- 在代谢性肝病中胆酸信号的文献综述.
- 对胆汁酸与关键受体 (FXR,TGR5) 相互作用的分析.
- 对基于胆酸的NASH治疗方法的研究的评估.
主要成果:
- 胆汁酸通过FXR和TGR5激活来调节脂质和葡萄糖平衡.
- 胆酸失调与NASH严重程度相关.
- 胆酸具有抗炎和抗纤维作用.
结论:
- 胆汁酸在治疗肝脏代谢障碍方面是至关重要的.
- 准胆酸通路为NASH提供了一个有前途的治疗策略.
- 胆酸可能有助于非酒精性脂肪肝疾病的分层和治疗.
更多相关视频
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...